Crystal structure of Plasmodium berghei lactate dehydrogenase indicates the unique structural differences of these enzymes are shared across the Plasmodium genus

Molecular and Biochemical Parasitology

Volumn 131, Issue 1, 2003, Pages 1-10

  Winter, V J ^a,b   Cameron, A ^a   Tranter, R ^a   Sessions, R B ^a   Brady, R L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b JOHN INNES CENTRE   (United Kingdom)

Author keywords

Crystallography; Glycolytic enzymes; Lactate dehydrogenase; Malaria; Plasmodium

Indexed keywords

LACTATE DEHYDROGENASE;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME BINDING; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN VERSUS NONHUMAN DATA; NONHUMAN; PLASMODIUM; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES DIFFERENCE; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS;

INSERTION SEQUENCES; MAMMALIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 0041326636     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(03)00170-1     Document Type: Article

References (26)

1. Olliaro P.L., Yuthavong Y. An overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol. Ther. 81(2):1999;91-110.
2. Subbayya I.N.S., Ray S.S., Balaram P., Balaram H. Metabolic enzymes as potential drug targets in Plasmodium falciparum. Indian J. Med. Res. 106:1997;79-94.
3. Ridley R.G., Dorn A., Vippagunta S.R., Vennerstrom J.L. Haematin (haem) polymerisation and its inhibition by quinoline antimalarials. Ann. Trop. Med. Parasitol. 91(5):1997;559-566.
4. Ridley R.G. Medical need scientific opportunity and the drive for antimalarial drugs. Nature. 415:2002;686-693.
5. Vander Jagt D.L., Hunsaker L.A., Heidrich J.E. Partial purification and characterisation of lactate dehydrogenase from Plasmodium falciparum. Mol. Biochem. Parasitol. 4:1981;255-264.
6. Dunn C.R., Banfield M.J., Barker J.J., Higham C.W., Moreton K.M., Turgut-Balik D.et al. The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design. Nat. Struct. Biol. 3(11):1996;912-915.
7. Gomez M.S., Piper R.C., Hunsaker L.A., Royer R.E., Deck L.M., Makler M.T.et al. Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum. Mol. Biochem. Parasitol. 90(1):1997;235-246.
8. Carlton J.M., Dame J.B. The Plasmodium vivax and P. berghei gene sequence tag projects. Parasitol. Today. 16(10):2000;409.
9. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
10. Navaza J., Saludjian P. AMoRe: an automated molecular replacement program package. Methods Enzymol. 276:1997;581-594.
11. Collaborative Computational Project Number 4 (CCP4). The CCP4 suite: programs for protein crystallography. Acta Crystallogr 1994;D50:760-3.
12. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein structures in electron-density maps and the location of errors in these models. Acta Crystallogr. A47:1991;110-119.
13. Eszes C.M., Sessions R.B., Clarke A.R., Moreton K.M., Holbrook J.J. Removal of substrate inhibition in a lactate dehydrogenase from human muscle by a single residue change. FEBS Lett. 399:1996;193-197.
14. Read J.A., Winter V.J., Eszes C.M., Sessions R.B., Brady R.L. Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. Proteins: Struct. Funct. Genet. 43:2001;175-185.
15. Wilks H.M., Hart K.W., Feeney R., Dunn C.R., Muirhead H., Chia W.N.et al. A specific, highly active malate dehydrogenase by redesign of a lactate dehydrogenase framework. Science. 242(4885):1988;1541-1544.
16. Fromm H.J. Evidence for ternary-complex formation with rabbit muscle lactic acid dehydrogenase, diphoshopyridine nucleotide and pyruvic acid. Biochim. Biophys. Acta. 52:1961;200-202.
17. Gutfreund H., Cantwell R., McMurray C.H., Criddle R.S., Hathaway G. The kinetics of the reversible inhibition of heart lactate dehydrogenase through the formation of the enzyme-oxidised nicotinamide-adenine dinucleotide-pyruvate compound. Biochem. J. 106:1968;683-687.
18. Coulson C.J., Rabin B.R. Inhibition of lactate dehydrogenase by high concentrations of pyruvate: the nature and removal of inhibitor. FEBS Lett. 3:1969;333-337.
19. Hewitt C.O., Sessions R.B., Dafforn T.R., Holbrook J.J. Protein engineering tests of a homology model of Plasmodium falciparum lactate dehydrogenase. Protein Eng. 10:1997;39-44.
20. Hewitt C.O., Eszes C.M., Sessions R.B., Moreton K.M., Dafforn T.R., Takej J.et al. A general method for relieving substrate inhibition in lactate dehydrogenases. Protein Eng. 12:1999;491-496.
21. Roth E.F. Jr., Raventos-Suarez C., Perkins M., Nagel R.L. Glutathione stability and oxidative stress in P. falciparum infection in vitro: response of normal and G6PD deficient cells. Biochem. Biophys Res. Commun. 109(2):1982;355-362.
22. Royer R.E., Deck L.M., Campos N.M., Hunsaker L.A., Vander Jagt D.L. Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles. J. Med. Chem. 29:1986;1799-1801.
23. Sessions R.B., Dewar V., Clarke A.R., Holbrook J.J. A model of Plasmodium falciparum lactate dehydrogenase and its implications for the design of improved antimalarials and the enhanced detection of parasitaemia. Protein Eng. 10:1997;301-306.
24. Kraulis P.J. Molscript - a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.
25. Merritt E.A., Bacon D.J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277:1997;505-524.
26. Nicholls A., Sharp K.A., Honig B. Protein folding and association. Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 11:1991;281-296.